Pathology and Oncology Research
Published by Frontiers Media S.A.
ISSN : 1219-4956 eISSN : 1532-2807
Abbreviation : Pathol. Oncol. Res.
Aims & Scope
Pathology & Oncology Research (POR) is an interdisciplinary Journal at the interface of pathology and oncology including the preclinical and translational research, diagnostics and therapy.
Furthermore, POR is an international forum for the rapid communication of reviews, original research, critical and topical reports with excellence and novelty.
Published quarterly, POR is dedicated to keeping scientists informed of developments on the selected biomedical fields bridging the gap between basic research and clinical medicine.
It is a special aim for POR to promote pathological and oncological publishing activity of colleagues in the Central and East European region.
The journal will be of interest to pathologists, and a broad range of experimental and clinical oncologists, and related experts.
POR is supported by an acknowledged international advisory board and the Arányi Fundation for modern pathology.
View Aims & ScopeMetrics & Ranking
Impact Factor
| Year | Value |
|---|---|
| 2025 | 2.3 |
| 2024 | 2.30 |
SJR (SCImago Journal Rank)
| Year | Value |
|---|---|
| 2024 | 0.714 |
Quartile
| Year | Value |
|---|---|
| 2024 | Q2 |
h-index
| Year | Value |
|---|---|
| 2024 | 64 |
Journal Rank
| Year | Value |
|---|---|
| 2024 | 7915 |
Journal Citation Indicator
| Year | Value |
|---|---|
| 2024 | 926 |
Impact Factor Trend
Abstracting & Indexing
Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.
Subjects & Keywords
Journal’s research areas, covering key disciplines and specialized sub-topics in Biochemistry, Genetics and Molecular Biology and Medicine, designed to support cutting-edge academic discovery.
Licensing & Copyright
This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.
Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.
Most Cited Articles
The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.
-
The role of matrix metalloproteinases in tumor angiogenesis and tumor metastasis
Citation: 483
Authors: Anitha, George
-
Heterogeneity of Prostate-Specific Membrane Antigen (PSMA) Expression in Prostate Carcinoma with Distant Metastasis
Citation: 323
Authors: Sebastian, Peter, Slave, Jonathan A., David, Gabor
-
Expression of GLUT1 and GLUT3 Glucose Transporters in Endometrial and Breast Cancers
Citation: 216
Authors: Anna, Katarzyna, Ewa, Paweł, Hanna, Andrzej, Magdalena
-
Clinicopathological Variation of Lauren Classification in Gastric Cancer
Citation: 189
Authors: Yun-Chi, Wen-Liang, Ruei-Fang, Chien-An, Muh-Hwa, Shu-Shun, Chew-Wen, Anna Fen-Yau, Yi-Ming, Kuo-Hung
-
The Role of the Mediators of Inflammation in Cancer Development
Citation: 188
Authors: José VerÃssimo, Ricardo Ney Oliveira, Carlos André Nunes, Thales Allyrio Araújo, Judson Welber VerÃssimo, Josélio Maria Galvão
-
Ferroptosis is Involved in Acetaminophen Induced Cell Death
Citation: 186
Authors: Tamás, Katalin, Tamás, József, András
-
Current Status and Perspective Biomarkers in AFP Negative HCC: Towards Screening for and Diagnosing Hepatocellular Carcinoma at an Earlier Stage
Citation: 186
Authors: Ping, Sanyun, Yalan, Xinliang, Shuo, Xuelan, Jiancheng
-
MEG3: an Oncogenic Long Non-coding RNA in Different Cancers
Citation: 155
Authors: Arwa, Mohammed, Narasimha Reddy
-
Hormone Replacement Therapy in Cancer Survivors – Review of the Literature
Citation: 149
Authors: Tamás, Mónika, Attila
-
Naringenin (Citrus Flavonone) Induces Growth Inhibition, Cell Cycle Arrest and Apoptosis in Human Hepatocellular Carcinoma Cells
Citation: 149
Authors: Duraikannu, Perumal